Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$266K Hold
1,363
0.04% 335
2026
Q1
$306K Hold
1,363
0.05% 311
2025
Q4
$328K Hold
1,363
0.05% 303
2025
Q3
$373K Hold
1,363
0.05% 304
2025
Q2
$352K Buy
1,363
+450
+49% +$107K 0.05% 299
2025
Q1
$204K Hold
913
0.04% 350
2024
Q4
$209K Sell
913
-47
-5% -$11.3K 0.04% 336
2024
Q3
$234K Buy
+960
New +$215K 0.04% 339

Other funds holding RMD

Chicago Trust's RMD Position: Q2 2026 in Review

Chicago Trust held its ResMed (RMD) position steady in Q2 2026 at 1,363 shares worth $266K. The position accounts for 0.04% of the portfolio, ranked #335.

Chicago Trust first reported a position in RMD in Q3 2024 and has held it in 8 quarters since. The position peaked at $373K in Q3 2025. 139 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Chicago Trust held 1,363 shares of ResMed worth $266K as of Q2 2026.
  • Chicago Trust left its ResMed share count unchanged in Q2 2026.
  • ResMed made up 0.04% of Chicago Trust's portfolio in Q2 2026, its #335 holding.
  • Chicago Trust first reported a position in ResMed in Q3 2024 and has held it in 8 quarters since.
  • Chicago Trust's ResMed position peaked at $373K in Q3 2025.
  • 139 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Chicago Trust's 13F filing for Q2 2026, filed 16 Jul 2026.